Prospector Partners LLC Nuvasive Inc Transaction History

Prospector Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$35.68 - $44.71 $19.4 Million - $24.3 Million	542,525 Added 378.92%	685,700 $28.3 Million
Q3 2022 Nov 10, 2022	SELL	$42.51 - $54.02 $1.13 Million - $1.43 Million	-26,500 Reduced 15.62%	143,175 $6.27 Million
Q2 2022 Aug 11, 2022	BUY	$46.84 - $59.75 $502,359 - $640,818	10,725 Added 6.75%	169,675 $8.34 Million
Q1 2022 May 12, 2022	SELL	$48.09 - $57.79 $454,450 - $546,115	-9,450 Reduced 5.61%	158,950 $9.01 Million
Q4 2021 Feb 11, 2022	BUY	$47.19 - $62.68 $736,164 - $977,808	15,600 Added 10.21%	168,400 $8.84 Million

Q3 2021 Nov 10, 2021	BUY	$56.91 - $67.81 $580,482 - $691,662	10,200 Added 7.15%	152,800 $9.15 Million
Q2 2021 Aug 11, 2021	SELL	$64.02 - $71.72 $144,045 - $161,370	-2,250 Reduced 1.55%	142,600 $9.67 Million
Q1 2021 May 13, 2021	BUY	$53.26 - $68.08 $3.66 Million - $4.68 Million	68,750 Added 90.34%	144,850 $9.5 Million
Q4 2020 Feb 11, 2021	BUY	$43.41 - $56.51 $3.3 Million - $4.3 Million	76,100 New	76,100 $4.29 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Prospector Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Prospector Partners LLC with notifications on news.